T cell phenotypes of the normal nasal mucosa: Induction of Th2 cytokines and CCR3 expression by IL-4

Journal of Immunology

Volumn 166, Issue 4, 2001, Pages 2303-2310

  Till, S J ^a   Jopling, L A ^a   Wachholz, P A ^a   Robson, R L ^a   Qin, S ^a   Andrew, D P ^a   Wu, L ^a   Van Neerven, J ^a   Williams, T J ^a   Durham, S R ^a   Sabroe, I ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR3; CYTOKINE; INTERLEUKIN 4;

ADULT; ARTICLE; ATOPY; CULTURE MEDIUM; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNE SYSTEM; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE; MALE; NORMAL HUMAN; NOSE MUCOSA; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH2 CELL;

EID: 0035865193     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.4.2303     Document Type: Article

References (51)

1. Worldwide variations in the prevalence of atopic symptoms: What does it all mean?
2. + Th1 phenotype
3. Nasal immune system: Distinctive Th0 and Th1/Th2 type environments in murine nasal-associated lymphoid tissues and nasal passage, respectively
4. Phenotypic distribution of T cells in human nasal mucosa differs from that in the gut
5. Phenotypic and functional analysis of mucosal T cells isolated from tissue explants of rat upper respiratory tract
6. 1 phase of the cell cycle
7. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions
8. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells
9. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
10. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
11. Differential regulation of chemokine receptors during dendritic cell maturation: A model for their trafficking properties
12. Cutting edge: Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells
13. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma: Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells
14. Monocyte chemotactic proteins in allergen-induced inflammation in the nasal mucosa: Effect of topical corticosteroids
15. Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation
16. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation
17. Eotaxin expression and eosinophilic inflammation in asthma
18. Eotaxin and monocyte chemotactic protein-4 mRNA expression in small airways of asthmatic and nonasthmatic individuals
19. Elevated plasma eotaxin levels in patients with acute asthma
20. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils
21. Differential regulation of eosinophil chemokine signalling via CCR3 and non-CCR3 pathways
22. Chemokine receptor usage by eosinophils: The importance of CCR3 demonstrated using an antagonistic monoclonal antibody
23. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells
24. A biopsy method to obtain high quality specimens of nasal mucosa
25. Flow cytometric measurement of intracellular cytokines
26. + T cells, analyzed at the single-cell level
27. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation
28. - lymphocyte subpopulation
29. + T cell subset with an unrestricted cytokine profile
30. + T cell clones
31. Simultaneous production of interleukin 2, interleukin 4 and interferon- gamma by activated human blood lymphocytes
32. Generation, persistence, and modulation of Th0 effector cells: Role of autocrine IL-4 and IFN-γ
33. Flow cytometric analysis of intraepithelial lymphocytes in the human nasal mucosa
34. Lymphocyte subsets of the nasal mucosa in perennial allergic rhinitis
35. + T cells are a potential source of IL-4 during primary immune response
36. Regulation of interleukin-12 expression in human monocytes: Selective priming by interferon-γ of lipopolysaccharide-inducible p35 and p40 genes
37. + cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy
38. Long-term clinical efficacy of grass-pollen immunotherapy
39. + T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-γ
40. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy
41. IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: Two key steps in specific immunotherapy
42. Interleukin-10 gene transfer to the airway regulates allergic mucosal sensitization in mice
43. Depletion of eosinophils in mice through the use of antibodies specific for C-C chemokine receptor 3 (CCR3)
44. CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo
45. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes
46. Chemotaxis of T lymphocytes on extracellular matrix proteins: Analysis of the in vitro method to quantitate chemotaxis of human T cells
47. Differential expression of binding sites for chemokine RANTES on human T lymphocytes
48. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling
49. Chemokines and T lymphocyte activation I. β chemokines costimulate human T lymphocyte activation in vitro
50. A small molecule antagonist of the chemokine receptors CCR1 and CCR3: Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry
51. + T-cell lines in atopic asthmatics, and atopic and nonatopic controls